Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia
Open Access
- 1 January 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 12 (6), R142
- https://doi.org/10.1186/cc7119
Abstract
The idea that multidrug resistance (MDR) to antibiotics in pathogens causing ventilator-associated pneumonia (VAP) is an independent risk factor for adverse outcome is still debated. We aimed to identify the determinants of MDR versus non-MDR microbial aetiology in VAP and assessed whether MDR versus non-MDR VAP was independently associated with increased 30-day mortality. We performed a retrospective analysis of a prospectively registered cohort of adult patients with microbiologically confirmed VAP, diagnosed at a university hospital intensive care unit during a three-year period. Determinants of MDR as compared with non-MDR microbial aetiology and impact of MDR versus non-MDR aetiology on mortality were investigated using multivariate logistic and competing risk regression analysis. MDR pathogens were involved in 52 of 192 episodes of VAP (27%): methicillin-resistant Staphylococcus aureus in 12 (6%), extended-spectrum β-lactamase producing Enterobacteriaceae in 28 (15%), MDR Pseudomonas aeruginosa and other non-fermenting pathogens in 12 (6%). Multivariable logistic regression identified the Charlson index of comorbidity (odds ratio (OR) = 1.38, 95% confidence interval (CI) = 1.08 to 1.75, p = 0.01) and previous exposure to more than two different antibiotic classes (OR = 5.11, 95% CI = 1.38 to 18.89, p = 0.01) as predictors of MDR aetiology. Thirty-day mortality after VAP diagnosis caused by MDR versus non-MDR was 37% and 20% (p = 0.02), respectively. A multivariate competing risk regression analysis showed that renal replacement therapy before VAP (standardised hazard ratio (SHR) = 2.69, 95% CI = 1.47 to 4.94, p = 0.01), the Charlson index of comorbidity (SHR = 1.21, 95% CI = 1.03 to 1.41, p = 0.03) and septic shock on admission to the intensive care unit (SHR = 1.86, 95% CI = 1.03 to 3.35, p = 0.03), but not MDR aetiology of VAP, were independent predictors of mortality. The risk of MDR pathogens causing VAP was mainly determined by comorbidity and prior exposure to more than two antibiotics. The increased mortality of VAP caused by MDR as compared with non-MDR pathogens was explained by more severe comorbidity and organ failure before VAP.Keywords
This publication has 43 references indexed in Scilit:
- Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks modelsCritical Care, 2008
- Quantitative Cultures for Diagnosing Ventilator-Associated Pneumonia: A CritiqueClinical Infectious Diseases, 2006
- Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit*Critical Care Medicine, 2006
- Is Methicillin Resistance Associated with a Worse Prognosis in Staphylococcus aureus Ventilator-Associated Pneumonia?Clinical Infectious Diseases, 2005
- A note on competing risks in survival data analysisBritish Journal of Cancer, 2004
- Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients*Critical Care Medicine, 2002
- Logistic or Cox model to identify risk factors of nosocomial infection: still a controversial issueIntensive Care Medicine, 2001
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- DIAGNOSING PNEUMONIA IN MECHANICALLY VENTILATED TRAUMA PATIENTSJournal Of Trauma-Injury Infection and Critical Care, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987